Product Information
ABIRATERONE ACETATE 250 MG TAB is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.7741 per EA under NDC 72205028492. Its NADAC has been published 73 times since May 14, 2025.
FDA first approved this application on Jul 10, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205028492
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ABIRATERONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA210686FDA Approved
7/10/2019
TE Code
AB
On Market Since
4/24/2024
Pharmacological Classes
Price Statistics
The NADAC for ABIRATERONE ACETATE 250 MG TAB has been published 73 times since May 14, 2025, and over the history we have for it it has declined 25.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7741 per EA |
|---|---|
| All-time high | $1.0638 (Oct 15, 2025) |
| All-time low | $0.7741 (Sep 23, 2026) |
| 52-week high | $1.0638 |
| 52-week low | $0.7741 |
| Median price | $0.8632 |
| Average price | $0.8991 |
| Largest weekly change | -8.9% (May 21, 2025) |
| Weeks tracked | 73 |
| Tracking since | May 14, 2025 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novadoz Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Abiraterone acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cytochrome P450 17A1 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ABIRATERONE ACETATE 250 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ABIRATERONE ACETATE 250 MG TAB, manufactured by Novadoz Pharmaceuticals LLC, is $0.7741 per EA (NDC 72205028492), effective Sep 30, 2026.
How has the price of ABIRATERONE ACETATE 250 MG TAB changed over time?
Over the history we have for it, the NADAC for ABIRATERONE ACETATE 250 MG TAB has declined 25.6%. It has been tracked across 73 weekly CMS publications since May 14, 2025.
What are the highest and lowest recorded NADAC prices for ABIRATERONE ACETATE 250 MG TAB?
Since May 14, 2025, the NADAC for ABIRATERONE ACETATE 250 MG TAB has ranged from a low of $0.7741 (Sep 23, 2026) to a high of $1.0638 (Oct 15, 2025), with a median of $0.8632 per EA.
Are there cheaper alternatives to ABIRATERONE ACETATE 250 MG TAB?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ABIRATERONE ACETATE 250 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures ABIRATERONE ACETATE 250 MG TAB?
ABIRATERONE ACETATE 250 MG TAB (NDC 72205028492) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.